Brunson EK, Schoch-Spana M, Carnes M, Hosangadi D, Long R, Ravi S, Taylor M, Trotochaud M, Veenema TG, on behalf of the CommuniVax Coalition. Carrying Equity in COVID-19 Vaccination Forward: Guidance Informed by Communities of Color. Baltimore, MD: Johns Hopkins Center for Health Security; 2021.

Vaccination of children aged 5 to 11 against Covid-19: Don’thesitate any longer – Académie nationale de médecine | Une institution dans son temps. (2022, January 25). https://www.academie-medecine.fr/vaccination-of-children-aged-5-to-11-against-covid-19-donthesitate-any-longer/?lang=en

Harris, J. E. (2021). COVID-19 Incidence and Hospitalization During the Delta Surge Were Inversely Related to Vaccination Coverage Among the Most Populous U.S. Counties (p. 2021.08.17.21262195). medRxiv. https://doi.org/10.1101/2021.08.17.21262195

ReconfigBehSci [@SciBeh]. (2021, December 10). Useful thread! [Tweet]. Twitter. https://twitter.com/SciBeh/status/1469208352819404805

John Bye. (2022, January 6). Despite repeatedly being proven wrong by subsequent events, covid disinformation groups like HART have constantly been given a platform on TV and radio throughout the pandemic. Even after #hartleaks revealed many of their members to be anti-vax conspiracy cranks. 🧵2: Broadcast https://t.co/I3unq04gij [Tweet]. @_johnbye. https://twitter.com/_johnbye/status/1479202308139409413

Scribner, H. (2022, January 29). A new COVID-19 variant surge ‘will happen again,’ experts say. Deseret News. https://www.deseret.com/coronavirus/2022/1/29/22904290/new-covid-19-variant-surge-next-major-coronavirus-mutation

Eric Topol. (2021, October 27). 'The benefit of a third [booster] dose in reducing transmission is sizeable and increases with vaccine coverage and contact rates among individuals." https://medrxiv.org/content/10.1101/2021.10.25.21265500v1 by @billygardner and @DiseaseEcology https://t.co/zAZcJgF1nJ [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1453153076165021696

Press, A. (2021, October 16). Covid ‘vaxathon’: Over 2.5% of New Zealanders get jabbed in one day. The Guardian. https://www.theguardian.com/world/2021/oct/16/covid-vaxathon-new-zealanders-jabbed-in-one-day

Sah, P., Moghadas, S. M., Vilches, T. N., Shoukat, A., Singer, B. H., Hotez, P. J., Schneider, E. C., & Galvani, A. P. (2021). Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00620-4

Pablo Tsukayama on Twitter. (n.d.). Twitter. Retrieved 4 October 2021, from https://twitter.com/pablotsukayama/status/1435725621599027202

Flu Vaccination Coverage, United States, 2018–19 Influenza Season | FluVaxView | Seasonal Influenza (Flu) | CDC. (2019, September 25). https://www.cdc.gov/flu/fluvaxview/coverage-1819estimates.htm

Conor Kelly. (2021, July 14). Correlation between vaccination coverage and COVID hospitalizations per million over time, by state https://t.co/g6AMTDXOzb [Tweet]. @CohoKelly. https://twitter.com/CohoKelly/status/1415310919266095113

Crocker-Buque, T., & Mounier-Jack, S. (2018). Vaccination in England: A review of why business as usual is not enough to maintain coverage. BMC Public Health, 18(1), 1351. https://doi.org/10.1186/s12889-018-6228-5

Lytras, T., Kopsachilis, F., Mouratidou, E., Papamichail, D., & Bonovas, S. (2015). Interventions to increase seasonal influenza vaccine coverage in healthcare workers: A systematic review and meta-regression analysis. Human Vaccines & Immunotherapeutics, 12(3), 671–681. https://doi.org/10.1080/21645515.2015.1106656

Prof. Christina Pagel. (2021, April 15). THREAD on VACCINATION & EQUITY in ENGLAND: I know I’ve tweeted about this before, but now we can look at how gaps by deprivation and ethnicity change with age groups and what that might mean... TLDR: widening gaps but access and communication will be key I suspect 1/5 [Tweet]. @chrischirp. https://twitter.com/chrischirp/status/1382725119773134848

Schmitt, H.-J., Booy, R., Aston, R., Van Damme, P., Schumacher, R. F., Campins, M., Rodrigo, C., Heikkinen, T., Weil-Olivier, C., Finn, A., Olcén, P., Fedson, D., & Peltola, H. (2007). How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Medicine, 5, 11. https://doi.org/10.1186/1741-7015-5-11

Jama, A., Ali, M., Lindstrand, A., Butler, R., & Kulane, A. (2018). Perspectives on the Measles, Mumps and Rubella Vaccination among Somali Mothers in Stockholm. International Journal of Environmental Research and Public Health, 15(11). https://doi.org/10.3390/ijerph15112428

Gangarosa, E. J., Galazka, A. M., Wolfe, C. R., Phillips, L. M., Miller, E., Chen, R. T., & Gangarosa, R. E. (1998). Impact of anti-vaccine movements on pertussis control: The untold story. The Lancet, 351(9099), 356–361. https://doi.org/10.1016/S0140-6736(97)04334-1

Final estimates for 2009–10 Seasonal Influenza and Influenza A (H1N1) 2009 Monovalent Vaccination Coverage – United States, August 2009 through May, 2010. | FluVaxView | Seasonal Influenza (Flu) | CDC. (2019, March 13). https://www.cdc.gov/flu/fluvaxview/coverage_0910estimates.htm

Kwon, Y., Cho, H.-Y., Lee, Y.-K., Bae, G.-R., & Lee, S.-G. (2010). Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate. Vaccine, 29(2), 161–165. https://doi.org/10.1016/j.vaccine.2010.10.063

Yufika, A., Wagner, A. L., Nawawi, Y., Wahyuniati, N., Anwar, S., Yusri, F., Haryanti, N., Wijayanti, N. P., Rizal, R., Fitriani, D., Maulida, N. F., Syahriza, M., Ikram, I., Fandoko, T. P., Syahadah, M., Asrizal, F. W., Aletta, A., Haryanto, S., Jamil, K. F., … Harapan, H. (2020). Parents’ hesitancy towards vaccination in Indonesia: A cross-sectional study in Indonesia. Vaccine, 38(11), 2592–2599. https://doi.org/10.1016/j.vaccine.2020.01.072

D’Ancona, F., D’Amario, C., Maraglino, F., Rezza, G., & Iannazzo, S. (2019). The law on compulsory vaccination in Italy: An update 2 years after the introduction. Eurosurveillance, 24(26). https://doi.org/10.2807/1560-7917.ES.2019.24.26.1900371

Plans-Rubió, P. (2012). The vaccination coverage required to establish herd immunity against influenza viruses. Preventive Medicine, 55(1), 72–77. https://doi.org/10.1016/j.ypmed.2012.02.015